The oral administration of luteolin (10 mg/kg) also significantly changed the levels of the mature BDNF, the noradrenaline and the dopamine in the hypothalamus of LPS-induced depression mice, and it didn’t significantly affect the level of pro-BDNF. The gene discussed is BDNF; the disease is depressive disorder.